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Abstract
We report an in vitro selection strategy to identify RNA sequences that mediate cap-independent 
translation initiation. This method entails the mRNA display of trillions of genomic fragments, 
selection for translation initiation, and high-throughput deep sequencing. We identified >12,000 
translation enhancing elements (TEEs) in the human genome, generated a high-resolution map of 
human TEE bearing regions (TBRs), and validated the function of a subset of sequences in vitro 
and in cells.
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Eukaryotic translation initiation usually follows a cap-dependent (CD) mechanism where the 
43S ribosomal pre-initiation complex is recruited to a 7-methylguanosine cap located at the 
5' end of the mRNA strand via recognition of the cap-binding complex eIF4F1,2. While 
progress over the years has provided a detailed structural and mechanistic understanding of 
each step in the CD process1,2, very little is known about the molecular basis of cap-
independent (CI) translation initiation3. CI translation occurs during normal cellular 
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processes (e.g., mitosis and apoptosis) or when the CD translation machinery is 
compromised by viral infection or disease4,5. To address this critical gap in our 
understanding of protein translation, we developed an in vitro selection strategy to identify 
sequences in the human genome that mediate CI translation initiation.
Our selection strategy relies on mRNA display, which is a cell-free method for covalently 
linking newly translated proteins to their encoding RNA message6. In this approach (Fig. 
1a), a genomic library is inserted into the 5' untranslated region (UTR) of a DNA construct 
containing the genetic information necessary for mRNA display. The library is in vitro 
transcribed into a pool of uncapped single-stranded mRNA that is photo-ligated at the 3' end 
to a DNA linker containing a 3' puromycin residue. When translated in vitro, RNA 
sequences that mediate CI translation initiation become covalently linked to a peptide 
affinity tag encoded in the open reading frame. Chemical bond formation between newly 
translated peptides and their encoding mRNA occurs via the natural peptidyl transferase 
activity of the ribosome, which recognizes puromycin as a tyrosyl-tRNA analogue (Fig. 1b). 
Functional RNAs are then isolated, reverse-transcribed, and amplified by PCR to regenerate 
the pool of DNA for another selection cycle.
We began the selection with a library of ~1013 RNA-DNA-puromycin molecules containing 
a random region of genomic fragments (~150 nts) that were derived from total human 
DNA7. The library was translated for 1 hour at 30°C and fusion formation was promoted by 
incubating the translation mixture overnight at −20°C under high salt conditions. mRNA-
peptide fusions were isolated from the crude lysate by oligo(dT) affinity purification, 
reverse-transcribed, and sequences displaying a His-6 affinity tag were immobilized on Ni-
NTA agarose beads. The beads were thoroughly washed to remove RNA molecules that did 
not form mRNA-peptide fusions or did not translate in the correct reading frame. mRNA-
peptide fusions that remained bound were selectively eluted with imidazole, exchanged into 
buffer, and amplified by PCR to reinitiate another selection cycle.
The abundance of mRNA-peptide fusions plateaued after six rounds of mRNA display, 
indicating that the library had become dominated by sequences that could enhance CI 
translation initiation (Fig. 1c). To assess the level of sequence diversity that remained in the 
pool, we cloned and sequenced members from the selection output. A total of 636 unique 
sequences were identified, 225 of which showed 100% identity to the human reference 
genome (hg18) (Supplementary Table 1). The remaining 411 sequences have high 
homology (85–99% identity), but contain small degrees of sequence variation that include 
single nucleotide polymorphisms in addition to small insertions and deletions 
(Supplementary Table 2). This level of variation is expected for individuals in a population, 
and it is known that functionally relevant sequences can differ between individual 
genomes8,9.
To test our selected sequences for functional activity in human cells, we constructed two 
luciferase reporter vectors (Fig. 2a)10. The first vector contained an unstructured 5' UTR 
designed to quantify the activity of the translation enhancing elements (TEEs). The second 
vector contained a stable stem-loop structure (ΔG = −58 kcal/mol) upstream of the insert, 
which blocks translation in the absence of an internal ribosomal entry site (IRES). 
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Translation of both mRNA templates containing a no-insert 13-nt control sequence 
confirmed that the stem-loop structure inhibits translation (~99% inhibition) in vitro and in 
cells (Fig. 2b). Quantitative realtime PCR (qRT-PCR) confirmed that the translational 
differences were not caused by differences in RNA expression.
Because cryptic splicing activity is a common cause of IRES misinterpretation11, we used a 
cytoplasmic expression system that bypasses nuclear expression12. In this system, 
mammalian cells transfected with an expression vector carrying a vaccinia virus (VACV)-
specific promoter are immediately infected with VACV. The virus produces its own RNA 
polymerase that recognizes the viral promoter and mediates RNA expression in the 
cytoplasm. We confirmed that nuclear expression did not contribute to translation by 
measuring the luciferase activity of transfected cells that were not infected with VACV. 
These cells yielded luciferase values equivalent to untreated control cells (data not shown).
Next, we tested the set of perfectly matched sequences for TEE and IRES function in human 
cells. Using the unstructured vector, we found that the selected sequences produce up to 
100-fold more luciferase than the no insert control (Fig. 2c), demonstrating that our in vitro 
selection strategy successfully enriched for sequences that enhance translation. 
Approximately 20% of our TEEs remain functional when tested in the 5' hairpin construct 
(Fig. 2c), suggesting that a large number of TEEs are capable of internal ribosomal 
initiation. To ensure that the observed IRES activity was not due to a cryptic promoter13, we 
screened 20 high activity sequences in HeLa cells using a stem-loop vector lacking the 
VACV promoter. This assay identified 8 sequences with modest to high cryptic promoter 
activity (Supplementary Fig. 1). We labeled the remaining 12 sequences human IRESs, as 
they do not exhibit cryptic promoter activity and are not an artifact of RNA splicing.
We then compared the set of 12 human IRESs to a set of 12 randomly chosen sequences 
from the starting library in the structured and unstructured luciferase reporter systems, both 
in HeLa cells and in HeLa cell lysate. Strong concordance was observed for the unstructured 
luciferase reporter vector, which showed ~100-fold greater translation enhancing activity in 
HeLa cells and in HeLa cell lysate as compared to the set of unselected sequences (Fig. 2d, 
Supplementary Table 3). A similar trend was observed for the 5' hairpin reporter, which 
showed that the selected sequences exhibit up to ~400-fold higher activity in cells and up to 
~100-fold higher activity in vitro than the unselected sequences (Fig. 2d, Supplementary 
Table 3). Collectively, these results establish the ability of our in vitro selection strategy to 
identify RNA sequences from the human genome that function as efficient translation 
enhancing elements, a subset of which function as IRESs.
One caveat of our HeLa cell assay is that the mRNA transcripts likely contain a 5' cap due to 
the strong capping enzymes encoded in the VACV genome12. This is not a concern for the 
hairpin construct as the stem-loop structure was shown to block CD translation initiation 
(Fig. 2b). However, in the case of the unstructured templates, where a 5' cap could aid 
translation initiation, further experiments are needed to define the activity of the TEE. We 
therefore selected 26 sequences that exhibited a range of TEE activity, but had no 
observable IRES activity (Fig. 2c). We then measured their luciferase activity under CI 
conditions relative to the no insert control. Consistent with the functional constraints of our 
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in vitro selection, the selected TEEs maintain their activity in the absence of a 5' cap 
(Supplementary Fig. 2). In some cases, activity increased significantly when the 5' cap was 
missing, suggesting that certain TEEs prefer CI translation initiation pathways. This 
observation provides new insight into the mechanism of translation initiation where the 5'-
cap is thought to inhibit alternative pathways14.
Since only a small number of human TEEs are known15, we decided to perform Illumina 
deep sequencing on the starting library (R0) and the selection output (R6). Sequence analysis 
revealed that only 2% of the R0 sequences remain in the pool after six rounds of selection. 
We aligned the sequences to the reference human genome (hg19) and identified 12,278 
unique regions that were enriched by at least 10-fold (see Methods, Supplementary Fig. 3, 
Supplementary Table 4). The in vitro selected TEE-bearing regions (TBRs) map to ~2 
million base pairs (Mb). A vast majority of TBRs were shorter than 250 bps (99.5%) and 
widely dispersed across all 24 chromosomes (Fig. 3a, Supplementary Fig. 4). Of these, 12% 
(1,532) mapped to genomic regions containing known genes, even though genic regions 
(introns and exons) account for ~40% of the human genome (Fig. 3b)16. This under-
abundance in genic regions may be a result of negative selection against TEEs aimed at 
avoiding disruptive translation in nature, which would be consistent with our results of TEE 
activity in vitro and in cells (Fig. 2). Moreover, the TBRs are preferentially found in the 5'-
UTR regions of genes (3-fold over-representation), which would suggest potential functional 
roles for these elements. We also observed a small, but statistically significant, enrichment 
of TBRs in long non-coding RNA (lncRNA) regions as compared to the entire human 
genome (12.2% vs. 11.5%, binomial test, P=0.003), which could lead to the production of 
novel proteins since these sites are located in intragenic regions of the genome.
GeneOntology analysis revealed that many TBRs associate with genes involved in signal 
transduction, cell communication, and neurological system development pathways 
(Supplementary Fig. 5). These functional categories are frequently reported for genes that 
have undergone adaptive evolution17,18. One such example are genes encoding glutamate 
receptors, which are important for neural communication, memory formation, learning, and 
regulation19. Among the 21 human genes encoding glutamate receptors, 8 harbor TBRs in 
their introns. Of these, two were enriched by more than 1000-fold after in vitro selection 
using mRNA display. Some of these sequences are flanked by regions that are highly 
conserved among species and show transcriptional activity in cells (Fig. 3c), indicating a 
possible role for TBRs in the translation of proteins involved in important developmental 
pathways.
In summary, we present an in vitro selection strategy that makes it possible to search entire 
genomes for RNA sequences that enhance cap-independent translation initiation. Using this 
technique, we identified >12,000 TEEs in the human genome, generated a high-resolution 
map of human TEE bearing regions, and validated the function of a subset of sequences in 
vitro and in cells. Our approach is time and cost effective, cell-line independent, and 
scalable, making it an effective tool for studying translation mechanisms in other genomes.
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Online Methods
Library assembly and mRNA display selection
The pool of fragmented human genomic DNA was previously constructed with conserved 
sequences flanking the random region7. The library was modified by overlap PCR to add all 
necessary sequence information required for mRNA display. This included a T7 RNA 
polymerase promoter site upstream of the random region and an open reading frame and 
photo-crosslinking site downstream of the random region. The open reading frame included 
a canonical AUG start site followed by a nucleotide sequence encoding a flexible linker and 
His-6 protein affinity tag. The library was amplified using the forward primer (5' 
TTCTAATACGACTCACTATAGGGGGATCCAAGCTTCAGACGTGCCTCACTACG) 
and reverse primer (5' 
ATAGCCGGTGTCCACTTCCATGATGATGGTGATGGTGGGCCATG 
GCTGAGCTTGACGCTTTGC). For each round of selection, 120 pmol of the dsDNA 
library was transcribed with T7 RNA polymerase into single-stranded RNA and purified by 
10% denaturing urea-PAGE gel. Purified RNA was photo-ligated to a psoralen-DNA-
puromycin linker (5'-psoralen-TAGCCGGTG-(PEG9)2-A15-ACC-puromycin) by irradiating 
at 366 nm for 15 minutes. The RNA-DNA-puromycin product was ethanol precipitated and 
the cross-linked RNA (400 pmol) was translated in vitro by incubating the library with 
micrococcal nuclease-treated rabbit reticulocyte lysate and 35S-methionine for 1 hour at 
30°C. The mixture was then incubated overnight at −20°C in the presence of KCl (600 mM) 
and MgCl2 (75 mM) to promote fusion formation. The mRNA-peptide fusion molecules 
were purified from the crude lysate using oligo (dT)-cellulose beads (NEB) and reverse 
transcribed with SuperScriptII (Invitrogen) by extending the DNA primer (5' 
TTTTTTTTTTTTTTTATCC ACTTCCATGATGATGGT) with dNTPs. Fusion molecules 
containing the correctly translated His-6 tag were isolated on Ni-NTA agarose beads 
(Qiagen). Functional sequences were recovered by eluting the column with 500 mM 
imidazole, dialyzing the sample into water, and amplifying the cDNA by PCR using 
previously described overlap PCR primers to add back the necessary sequences for mRNA 
display. The selection progress was monitored by measuring the fraction of S35-labeled 
mRNA-peptide fusions that bound to and eluted from the oligo (dT) and Ni-NTA affinity 
columns. After 6 rounds of selection and amplification, the dsDNA library was cloned into a 
pJET plasmid (Fermentas), and individual isolates were sequenced at the ASU core DNA 
sequencing facility.
Luciferase reporter plasmids
A monocistronic luciferase reporter vector with an unstructured 5' UTR, that contains both a 
T7 RNA polymerase promoter and a vaccinia virus synthetic late promoter (slp), was 
constructed from a pT3_R-luc<IRES>F-luc(pA)62 luciferase reporter plasmid10. The vector 
was first modified using PCR to exchange the T3 promoter with a T7 promoter (forward 
primer 5' 
GATCCCGGGATTAATAACGACTCACTATAGGGAACAAAAGCTGGGTACCGG and 
reverse primer 5' GATCCCGGGTGCGCGCTTGGCGTAATCATGG). The resulting PCR 
product was cut with SmaI restriction endonuclease, and recircularized using T4 DNA 
ligase. A synthetic double-stranded DNA molecule containing the slp promoter was inserted 
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immediately downstream of the T7 promoter using KpnI and XhoI restriction sites. Finally, 
the renilla luciferase gene was removed by PCR using forward primer 5' 
ACTAGGATCCGCTTCTGTTGGGAAATGC and reverse primer 5' 
CGCGGATCCAAGCTTATCGATACCGTCGAC. The PCR product was cut with BamHI 
restriction endonuclease and recircularized using T4 DNA ligase. To assay for IRES 
activity, two additional luciferase reporter vectors were used, both of which contain a stable 
stem-loop structure in the 5' UTR. The first vector was the pT7-stem_F-luc(pA)62 luciferase 
reporter plasmid described previously2. This plasmid contains a T7 RNA polymerase 
promoter upstream of the stem-loop. The second vector was constructed by removing the 
stem-loop structure from pT7-stem_F-luc(pA)62 using StuI and XhoI restriction sites and 
reciprocally inserting it into the unstructured vector, immediately downstream of the slp 
promoter. Plasmids to assay for cryptic promoter activity were generated by removing the 
T7 and slp promoters from the unstructured vector using SmaI and BamHI restriction sites. 
T4 DNA ligase was then used to insert a 22-nucleotide spacer (5' 
ATAGCGCCACCGAGATATCTGG 3') in place of the promoters. To insert the human 
genomic sequences into the luciferase reporter vectors, the genomic fragments were 
amplified by PCR (forward primer 5' TAGGGGGATCCCAGAC GTGCCTCACTACGT 
and reverse primer 5' TGGGCCATGGCTGAGCTTGACGCTTTGCT) to add BamHI and 
NcoI restriction sites to the 5' and 3' ends respectively. The PCR products were then 
reciprocally inserted into the vectors immediately upstream of the luciferase-coding region 
by restriction endonuclease digestion.
Cell culture
HeLa cells, obtained from American Type Culture Collection, were maintained in DMEM 
(Invitrogen) supplemented with 5% fetal bovine serum (HyClone) and 5 μg/mL gentamicin 
(Invitrogen). Cells were kept at 37°C in a humidified atmosphere containing 5% CO2. The 
cells were free of mycoplasma contamination, as determined by PCR during routine 
monitoring of cell lysates.
Luciferase reporter assay
HeLa cells were seeded at a density of 15,000 cells per well in white 96-well plates 18 hours 
prior to transfection. Cells were transfected with a complex of the luciferase reporter 
plasmid (200 ng) and Lipofectamine 2000 (0.5 μl) in Opti-MEM (Invitrogen), and 
immediately infected with the Copenhagen strain (VC-2) of wild-type vaccinia virus at a 
multiplicity of infection (m.o.i) of 5 PFU/cell. Cells were lysed (6 hours post-infection) in 
the 96-well plates and luciferase activity was measured using the Promega Luciferase Assay 
System with a Glomax microplate luminometer (Promega). Cell-free characterization of the 
top translation enhancing sequences was performed using a Human In vitro Protein 
Expression Kit (Pierce). Luciferase expression was achieved following manufacturer's 
protocols using 300 ng of linear template for a two-hour transcription at 32°C followed by a 
90 min translation at 30°C.
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RNA characterization
A portion of the cells used in the luciferase reporter transfection studies were separately 
lysed to evaluate the quality of the cellular RNA. RNA isolation was performed using the 
PerfectPure RNA cultured cell kit (5 Prime) according to manufacturer's protocol. Isolated 
RNA was reverse transcribed with an oligo (dT) primer and Superscript II (Invitrogen). 
Realtime PCR (iQ™ SYBR® Green Supermix, Bio-Rad) was used to determine the mRNA 
levels of luciferase (forward primer 5' GCTGGGCGTTAATCAGAGAG and reverse primer 
5' GTGTTCGTCTTCGTCCCAGT) as well as the housekeeping gene hypoxanthine-guanine 
phosphoribosyltransferase (HPRT, forward primer 5' TGCTGAGGATTTGGAAAGGGTG 
and reverse primer 5' CCTTGAGCACACAGAGGGCTAC). Using the ΔΔCt method, the 
amount of luciferase mRNA was normalized to HPRT mRNA levels. Luminescence values 
were then adjusted according to the normalized luciferase mRNA levels.
Sequence analysis
An in-house pipeline was used to process Illumina HiSeq sequences. First, base-calling and 
quality control were performed using the Illumina HiSeq2000 according to the 
manufacturer's instructions (Supplementary Table 4a). The average length of reads was 80 
base pairs. To detect and trim the PCR primers at both ends of each Illumina read, we used 
the “cutadapt” program (http://code.google.com/p/cutadapt/) allowing a maximum of 2 
mismatches. Both primers were detected in a vast majority of the reads (85% in R0 and 98% 
in R6). However, multiple primers were found to be concatenated in some reads, which is 
common for HiSeq data. For these reads, we used “cutadapt” iteratively until all primer 
sequences were trimmed. Finally, reads shorter than 35 bps or longer than 75 bps were 
discarded, because they contained too many or no copies of the primers (Supplementary 
Table 4b). To ensure correct orientation for all reads, sequences were reverse complemented 
if the 5' primer was present at the 3' end or the 3' primer was present at the 5' end.
All trimmed reads were aligned to the human reference genome build 19 (hg19) using 
iterative execution of “bowtie” alignment and end trimmings20. Sequentially, with one base 
at a time, 16 bps from the 3' end, 5 bps from the 5' end, and another 15 bps from the 3' end 
were trimmed from unaligned reads, which is done to ensure low-quality base calls do not 
interfere with sequence alignment. In all iterations, “bowtie” was executed in “-n” mode 
with “-n 2 –e 70” setting. Reads uniquely mapped to exactly one location, 2 – 10 locations, 
and more than 10 locations in the hg19 genome were denoted as “single-copy”, “low-copy” 
and “high-copy” reads, respectively (Supplementary Table 4c).
Based on reads mapped to the human genome, we used the command-line version of the 
CisGenome21 to call peaks where R6 served as the positive sample and R0 served as the 
negative control sample; parameters were set as “-c 1 -m 10 -w 60 -s 20 -p 0.009948 -br 0 -
ssf 0”. Because TEEs are directional, we applied single-strand filtering and labeled a peak as 
“forward” or “reverse” depending on which strand of the genome it resided on. To further 
reduce spurious peaks, we required a peak to have a strand-specific global false discovery 
rate less than 10%, total number of reads > 10 and at least 1 read present in the R0 library 
(Supplementary Table 4d). The CisGenome program compared the normalized number of 
R6 reads with the normalized number of R0 reads in a peak, which represented the fold 
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enrichment level (Supplementary Table 4e). Because repetitive elements can complicate 
downstream analysis, we focused on peaks derived from single-copy reads. Furthermore, 
single-copy peaks containing low-complexity sequences were detected using RepeatMasker 
(www.repeatmasker.org) with parameters “-noint –species human –q”. Peaks with no repeat 
masked and with more than 10-fold enrichment were called putative TEE-bearing regions 
(TBRs) (Supplementary Table 4f). Chromosomal distributions of TBRs were converted into 
ideograms using the Idiographica website22.
We performed bionomical tests for evaluating the null hypothesis that TBRs are randomly 
distributed in the human genome. In this case, the random probability of a base to belong to 
a genomic category was first estimated using the RefSeq database. This was equal to 0.43, 
0.005, 0.005, and 0.57, for genes (all exons and introns), 5'-UTRs, 3'-UTRs, and inter-genic 
regions, respectively. We also conducted GeneOntology enrichment analyses to identify 
functional categories that were over-represented in the collection of genes found to harbor 
TBRs (Supplementary Fig. 5). We used GeneOntology classifications from the 
PANTHER23 website and applied Bonferroni correction for multiple testing, using a cutoff 
p-value of 10−3. Enriched biological processes were reported (Supplementary Fig. 5). 
Because the naïve library was generated by randomly sampling the genome, longer genes 
were sampled more often than shorter genes. To account for this gene length effect, we 
constructed a background sample from the human genome that matched the length 
distribution of TBR genes, and redid the GeneOntology enrichment analysis. This process 
was repeated ten times. The Bonferroni corrected p-values from each analysis were 
combined using Fisher's method. Biological processes that have significant p-values (<0.01) 
in at least one of these ten gene-length adjusted analyses or have significant combined p-
values (χ2 p-value <0.05) were highlighted.
Illumina library construction and generation
The Illumina sequencing libraries were generated according to Illumina DNA Sample Kit 
Instructions (Illumina Part # 0801– 0303). The protocol was modified such that enzymes 
were obtained from other suppliers, as previously described24. Briefly, DNA from the output 
of round 6 was end-repaired and phosphorylated using the `End-It' kit (Epicentre). The 
blunt, phosphorylated ends were treated with Klenow fragment (3' to 5' exo minus; NEB) 
and dATP to yield a 3' A overhang for ligation of Illumina's adapters. Following adapter 
ligation (LigaFast, Promega) DNA was PCR amplified with Illumina genomic DNA primers 
1.1 and 2.1. The final libraries were band-isolated (150–300 bp) from an agarose gel to 
remove residual primers and adapters. Purified library DNA was captured on an Illumina 
flowcell for cluster generation and sequenced on an Illumina HiSeq 2000 following the 
manufacturer's protocols.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. In vitro selection of RNA elements that mediate cap-independent (CI) translation
(a) A library of human genomic DNA fragments was inserted into a DNA cassette 
containing all of the sequence information necessary for mRNA display. For each selection 
round, the dsDNA pool was in vitro transcribed into ssRNA, conjugated to a DNA-
puromycin linker, and translated in vitro. Uncapped mRNA sequences that initiate 
translation of an intact ORF become covalently linked to a His-6 protein affinity tag 
encoded in the RNA message. Functional molecules are recovered, reverse transcribed, and 
amplified by PCR to generate the DNA for the next selection cycle. (b) RNA-protein fusion 
molecules are generated via the natural peptidyl transferase activity of the ribosome. (c) 
Selection progress was monitored by measuring the fraction of S35-labeled fusion molecules 
recovered from the oligo-dT and Ni-NTA affinity columns.
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Figure 2. Functional analysis of selected TEEs in human cells and in vitro
(a) Firefly luciferase reporter with or without a stable stem-loop structure in the 5' UTR. (b) 
Translation efficiency of a no-insert control in the absence and presence of the stem loop 
structure assayed in HeLa cell lysate and in HeLa cells. (c) Translation enhancing activity of 
225 representative sequences after six rounds of in vitro selection. Sequences were assayed 
in the absence (top) or presence (bottom) of the stem-loop structure in HeLa cells. Results 
were compared to an unstructured 13-nucleotide insert (red bar), which defined the basal 
level of bioluminescence activity for the reporter plasmid. (d) A set of twelve high activity 
sequences (red) were compared to an equal number of unselected sequences from the 
starting library (blue) in the absence (top) and presence (bottom) of the stem-loop structure 
in HeLa cells and in HeLa cell lysate. Fold enhancement of translation was measured 
relative to a no insert reporter containing 13-nt unstructured sequence in place of the TEE. 
Luciferase values were normalized to luciferase mRNA levels for cell-based experiments in 
(b) and (d), however not in (c).
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Figure 3. Genomic landscape of human TEEs
(a) Chromosomal ideogram of TBRs with different levels of fold-change (FC) between the 
starting (R0) and the selected library (R6): Low (10–99 FC; blue), Medium (100–999 FC; 
green), and High (>=1,000 FC; red). The blank regions in the chromosome correspond to the 
unsequenced regions in the reference genome (hg19). The total number of TBRs per 
chromosome is displayed in the inset and is sorted by enrichment levels. (b) Genetic 
distribution of TBRs revealed under-representation in intragenic and exonic regions 
(binomial test, both p < 10−16), and over-representation in 5'-UTRs (binomial test, p < 
10−16). (c) Genomic context of a TBR residing in an intron of the GRIN2B gene. This TBR 
was enriched by over 1,000 times. It overlaps with active nucleosome binding sites in the 
ENCODE cell lines GM12878 and K562, and is upstream of a highly conserved region 
among placental mammals. Population polymophisms were found upstream, but not within 
or downstream, of this TBR.
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